Mirror-Image D-Core Streptavidin Exhibits Reduced Immunogenicity and Comparable Biodistribution to Natural Core
Masatoshi Suganuma1, Aya Sugyo2, Hitomi Sudo2
1Central Research Laboratories, Sysmex Corporation; Healthcare Science Hub Tokyo, 1-17-8 Shinkiba, Koto-ku, Tokyo 136-0082, Japan.
Abstract:
The clinical application of natural core streptavidin remains unrealized owing to its immunogenicity and interference from endogenous D-biotin. These limitations could be addressed using D-core streptavidin, the mirror-image form. Here, we evaluated the immunogenicity and biodistribution of D-core streptavidin in mice. Intraperitoneal administration of natural core streptavidin induced antibodies against streptavidin, whereas no antibody production was observed for D-core streptavidin. The protease assay indicated that proteolysis by cathepsin B differed between D-core streptavidin and the natural core form. The difference in degradation by cathepsin B in non-denatured conditions may contribute to the reduced immunogenicity of D-core streptavidin. Biodistribution studies revealed no significant differences between D-core and natural core streptavidins in tumor-bearing mice. These findings support the further development of D-core streptavidin in combination with L-biotin for in vivo applications.
More Related Videos
Related Concept Videos
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Equivalence: In Vitro and In Vivo Bioequivalence


